Join us for the Industry Innovation Series on “Biotech Solutions for Cancer Therapeutics” at La Trobe University’s Bundoora campus, where Dr Sarah Herridge (Director of Research & Scientific Affairs, BioNTech Australia) will present on BioNTech’s mRNA immunotherapies in oncology. Dr Herridge will explore how mRNA-based technologies are reshaping cancer therapeutics, highlighting BioNTech’s translational research efforts and its planned clinical GMP manufacturing facility. The event brings together leading industry and academic voices to discuss breakthroughs in cancer therapies.